Portola/Novartis Plan Phase III Trial For Elinogrel, With Eyes For Plavix Market
This article was originally published in The Pink Sheet Daily
Executive Summary
Portola's anti-thrombotic vision: Execs discuss possibilities for two partnered, Phase III ready drugs - elinogrel and betrixaban.